OpenArc Corporate Advisory’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.68M Sell
21,519
-9,418
-30% -$760K 0.02% 276
2026
Q1
$2.68M Sell
30,937
-723
-2% -$69.3K 0.04% 209
2025
Q4
$3.04M Buy
+31,660
New +$3.08M 0.05% 181

Other funds holding MDT

OpenArc Corporate Advisory's MDT Position: Q2 2026 in Review

OpenArc Corporate Advisory reduced its Medtronic (MDT) stake by 30% in Q2 2026, selling an estimated $760K and leaving 21,519 shares worth $1.68M. The position accounts for 0.02% of the portfolio, ranked #276.

OpenArc Corporate Advisory first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.04M in Q4 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • OpenArc Corporate Advisory held 21,519 shares of Medtronic worth $1.68M as of Q2 2026.
  • OpenArc Corporate Advisory sold 9,418 Medtronic shares in Q2 2026, an estimated $760K.
  • Medtronic made up 0.02% of OpenArc Corporate Advisory's portfolio in Q2 2026, its #276 holding.
  • OpenArc Corporate Advisory first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
  • OpenArc Corporate Advisory's Medtronic position peaked at $3.04M in Q4 2025.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.